Clinical Trial Update: Safety and Tolerability Study for T-1201 Injection 100 mg Kit in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 safety and tolerability trial update for T-1201 in patients with advanced solid tumors; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• T-1201

Snippet

Sponsor: Taivex Therapeutics Corporation | Conditions: Advanced Solid Tumor | Phase 1 | Status: RECRUITING